一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> European Journal of Drug Metabolism and Pharmacokinetics >>article
European Journal of Drug Metabolism and Pharmacokinetics

European Journal of Drug Metabolism and Pharmacokinetics

IF: 1.9
Download PDF

Uridine 5′-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro–In Vivo Extrapolation (IVIVE)

Published:20 April 2024 DOI: 10.1007/s13318-024-00895-3
Ewelina Gabor-Worwa, Anna Kowal-Chwast, Nilesh Gaud, Dawid Gogola, Peter Littlewood, Marek Smoluch, Krzysztof Brzózka, Kamil Kus

Abstract

Background and Objective

The prediction of pharmacokinetic parameters for drugs metabolised by cytochrome P450 enzymes has been the subject of active research for many years, while the application of in vitro–in vivo extrapolation (IVIVE) techniques for non-cytochrome P450 enzymes has not been thoroughly evaluated. There is still no established quantitative method for predicting hepatic clearance of drugs metabolised by uridine 5′-diphospho-glucuronosyltransferases (UGTs), not to mention those which undergo hepatic uptake. The objective of the study was to predict the human hepatic clearance for telmisartan based on in vitro metabolic stability and hepatic uptake results.

Methods

Telmisartan was examined in liver systems, allowing to estimate intrinsic clearance (CLint, in vitro) based on the substrate disappearance rate with the use of liquid chromatography tandem mass spectrometry (LC-MS/MS) technique. Obtained CLint, in vitro values were corrected for corresponding unbound fractions. Prediction of human hepatic clearance was made from scaled unbound CLint, in vitro data with the use of the well-stirred model, and finally referenced to the literature value of observed clearance in humans, allowing determination of the essential scaling factors.

Results

The in vitro scaled CLint, in vitro by UGT1A3 was assessed using three systems, human hepatocytes, liver microsomes, and recombinant enzymes. Obtained values were scaled and hepatic metabolism clearance was predicted, resulting in significant clearance underprediction. Utilization of the extended clearance concept (ECC) and hepatic uptake improved prediction of hepatic metabolism clearance. The scaling factors for hepatocytes, assessing the in vitro–in vivo difference, changed from sixfold difference to only twofold difference with the application of the ECC.

Conclusions

The study showed that taking into consideration hepatic uptake of a drug allows us to obtain satisfactory scaling factors, hence enabling the prediction of in vivo hepatic glucuronidation from in vitro data.

Substances (8)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
Telmisartan 144701-48-4 C33H30N4O2 952 suppliers $5.00-$1250.00
Telmisartan 144701-48-4 C33H30N4O2 952 suppliers $5.00-$1250.00
Telmisartan 144701-48-4 C33H30N4O2 952 suppliers $5.00-$1250.00
Telmisartan 144701-48-4 C33H30N4O2 952 suppliers $5.00-$1250.00
Telmisartan 144701-48-4 - Inquiry
Telmisartan 144701-48-4 - Inquiry

Similar articles

IF:5.7

4-Methylumbelliferone Inhibits Angiogenesis in Vitro and in Vivo

Journal of Agricultural and Food Chemistry Javier A. García-Vilas, Ana R. Quesada,etc Published: 12 April 2013
IF:4.6

In Vitro and In Vivo Neuroprotective Effects of Sarcosine.

ACS Applied Bio Materials Arzugül Tanas, ?zlem ?zdemir Tozlu,etc Published: 15 October 2022
IF:3.8

Salidroside inhibits the growth of human breast cancer in vitro and in vivo.

Oncology reports Gang Zhao, Aiping Shi,etc Published: 1 May 2015
容城县| 舒兰市| 桦南县| 铜鼓县| 罗山县| 麦盖提县| 黄大仙区| 开平市| 五大连池市| 铜鼓县| 海淀区| 双桥区| 柯坪县| 上犹县| 平武县| 黄骅市| 郯城县| 峡江县| 湖口县| 克山县| 神农架林区| 崇文区| 白朗县| 思南县| 万源市| 武功县| 张家界市| 凭祥市| 西峡县| 湾仔区| 探索| 榆林市| 龙州县| 阜宁县| 香河县| 平江县| 深泽县| 潮州市| 右玉县| 天峨县| 建阳市|